- Trials with a EudraCT protocol (727)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
727 result(s) found for: Biochemistry.
Displaying page 1 of 37.
EudraCT Number: 2021-005629-25 | Sponsor Protocol Number: 215301 | Start Date*: 2022-08-25 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals SA | |||||||||||||
Full Title: A Phase 1/2a, open-label, randomised, controlled, multi-country, dose-escalation study to assess the safety and immunogenicity of AS37 in combination with the Hepatitis B surface antigen (HBsAg), a... | |||||||||||||
Medical condition: Healthy volunteers (Hepatitis B Virus infection) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001561-88 | Sponsor Protocol Number: CICL670ATRO4 | Start Date*: 2016-04-14 |
Sponsor Name:Novartis Pharmaceuticals | ||
Full Title: A Phase II, Multi-center, Single-arm, Prospective Study to Evaluate the Safety and Efficacy of Deferasirox in Beta-thalassemia Major Patients After Hematopoietic Stem Cell Transplantation | ||
Medical condition: -Iron overload | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-001005-16 | Sponsor Protocol Number: CL2-44819-004 | Start Date*: 2016-09-21 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event. International, multi-centre, randomized, double-blind placebo-controlled phase II study. | |||||||||||||
Medical condition: Post stroke recovery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) SE (Completed) DE (Completed) BE (Completed) NL (Completed) ES (Completed) PL (Completed) CZ (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004199-12 | Sponsor Protocol Number: RG_11-139vitd | Start Date*: 2012-01-04 |
Sponsor Name:University of Birmingham | ||
Full Title: An open label dose ranging study to optimise vitamin D levels prior to oesophagectomy | ||
Medical condition: perioperative inflammation in patients undergoing oesophagectomy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004610-29 | Sponsor Protocol Number: 2014.001 | Start Date*: 2015-02-18 |
Sponsor Name:Skanes University Hospital | ||
Full Title: Ciclosporin to Protect Renal function In Cardiac Surgery. CiPRICS. A Phase II Double Blind Randomized Placebo Controlled Study. | ||
Medical condition: Renal dysfunction after CABG surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003367-40 | Sponsor Protocol Number: 2007/049/HP | Start Date*: 2009-03-03 |
Sponsor Name:CHU de Rouen | ||
Full Title: Pilot study of the effect of a substance P antagonist, aprepitant, on aldosterone and cortisol secretions in healthy volunteers | ||
Medical condition: The aim is to measure plasma aldosterone and cortisol concentrations in basal conditions and in response to different stimulation tests of the adrenal function | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003885-14 | Sponsor Protocol Number: XRP6976J/3502 | Start Date*: 2005-03-30 |
Sponsor Name:Aventis Pharma, S.A. | ||
Full Title: Multidisciplinar, multicenter, randomized phase III clinical trial comparing taxotere plus estramustine phosphate plus prednisone, versus taxotere prednisone, in advanced prostate carcinoma patient... | ||
Medical condition: Acvanced prostate carcinoma | ||
Disease: | ||
Population Age: Adults | Gender: | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002425-30 | Sponsor Protocol Number: 0171 | Start Date*: 2020-03-17 |
Sponsor Name:Theravance Biopharma Ireland Limited | ||
Full Title: A Phase 3, 182-week, Open-Label, Extension Study to Investigate the Safety and Tolerability Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension (symptomatic nOH) in Subjects... | ||
Medical condition: Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) ES (Prematurely Ended) PL (Completed) EE (Completed) FR (Completed) PT (Prematurely Ended) AT (Prematurely Ended) BG (Prematurely Ended) DE (Prematurely Ended) HU (Completed) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-002741-21 | Sponsor Protocol Number: AAA-Ga-TOC-EU-01 | Start Date*: 2014-10-23 | |||||||||||
Sponsor Name:Advanced Accelerator Applications SA | |||||||||||||
Full Title: Safety and tolerability of 68Ga-DOTATOC for injection in patients with proven gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). | |||||||||||||
Medical condition: Patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001157-32 | Sponsor Protocol Number: A4250-003 | Start Date*: 2015-05-13 |
Sponsor Name:Albireo AB | ||
Full Title: An exploratory Phase II Study to demonstrate the Safety and Efficacy of A4250 in Children with Cholestatic Pruritus | ||
Medical condition: Patients wih Cholestatic Pruritus | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) DK (Completed) DE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002864-24 | Sponsor Protocol Number: UMCN-AKF 06.02 | Start Date*: 2006-09-25 | |||||||||||
Sponsor Name:Dept. of Clinical Pharmacy, Radboud UMC Nijmegen, The Netherlands | |||||||||||||
Full Title: Drug interactions between ATOvaquone used in MAlaria prophylaxis and antiretroviral agents in HIV-1 infected patients (ATOMA) | |||||||||||||
Medical condition: malaria prophylaxis in HIV patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-005165-49 | Sponsor Protocol Number: PLX-HF-01 | Start Date*: 2018-09-24 | |||||||||||
Sponsor Name:Pluristem Ltd. | |||||||||||||
Full Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, Designed to Determine the Efficacy, Safety, and Tolerability of Intramuscular Administration of Allogeneic PLX-PAD Cell... | |||||||||||||
Medical condition: Muscle Injury Following Arthroplasty for Hip Fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (GB - no longer in EU/EEA) DK (Completed) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004987-91 | Sponsor Protocol Number: 2020/ABM/01/00098 | Start Date*: 2021-11-17 | |||||||||||
Sponsor Name:Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu | |||||||||||||
Full Title: Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic can... | |||||||||||||
Medical condition: Unresectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020233-56 | Sponsor Protocol Number: DC-006 | Start Date*: 2011-03-24 |
Sponsor Name:Oslo University Hospital | ||
Full Title: PHASE I/II TRIAL OF VACCINE THERAPY IN RELAPSED AND PLATINUM RESISTANT EPITHELIAL OVARIAN CANCER PATIENTS USING AUTOLOGOUS DENDRITIC CELLS LOADED WITH AMPLIFIED OVARIAN CANCER STEM CELL mRNA, hTE... | ||
Medical condition: Relapsed and platinum resistant epithelial ovarian carcinoma patients that have received one line of non-platinum chemotherapy in resistance disease setting. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NO (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000985-12 | Sponsor Protocol Number: 1719-B | Start Date*: 2018-11-26 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Near-infrared fluorescence imaging in kidney transplantations using ZW800-1 for perfusion assessment: a pilot study | ||
Medical condition: Patients undergoing a living-donor kidney transplantation (living kidney donor and kidney recipient) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001620-31 | Sponsor Protocol Number: CZB/4/622 | Start Date*: 2009-09-14 |
Sponsor Name:NHS Highland | ||
Full Title: Glutathione Status in Platelets From Patients With Type 2 Diabetes: Therapeutic Potential of N-acetylcysteine to Help Prevent Platelet Hyperaggregability | ||
Medical condition: Platelet Aggregation in type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018584-41 | Sponsor Protocol Number: P10.YYY | Start Date*: 2010-07-23 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: A phase II study of ARA290 as therapeutic strategy in no-option critical limb ischemia patients. | |||||||||||||
Medical condition: Critical Limb Ischemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004357-13 | Sponsor Protocol Number: CTH201401 | Start Date*: 2015-03-18 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Coagaulation in patients with atrial fibrillation: The effect of dabigatran | |||||||||||||
Medical condition: Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004305-25 | Sponsor Protocol Number: EPU P25 | Start Date*: 2006-09-15 |
Sponsor Name:Maastricht University | ||
Full Title: Residual effects of zopiclone 7.5 mg and temazepam 20 mg on cognition and actual driving performance in healthy elderly | ||
Medical condition: Healthy elderly volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004409-42 | Sponsor Protocol Number: LRP/LUBT010/2016/008 | Start Date*: 2020-11-23 | |||||||||||
Sponsor Name:Lupin Limited (Biotechnology Division) | |||||||||||||
Full Title: A Global, Phase III, Double Blind, Randomized Controlled Study to Compare the Efficacy, Safety & Immunogenicity of LUBT010 with Lucentis® in Patients with Neovascular Age-Related Macular Degeneration | |||||||||||||
Medical condition: Neovascular Age Related Macular Degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
